Norgestimate/Ethinyl Estradiol Tablets

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D2-25-R-0003

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
The Defense Logistics Agency (DLA) Troop Support has issued an active solicitation (Procurement Identifier: SPE2D2-25-R-0003) for the supply of Norgestimate/Ethinyl Estradiol Tablets. This procurement falls under the North American Industry Classification System (NAICS) code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further classified under Product Service Code 6505, indicating a focus on drugs and biologicals. The primary objective of this solicitation is to secure a reliable source of Norgestimate/Ethinyl Estradiol Tablets, a pharmaceutical product commonly used in contraceptive applications. The intended outcome is to ensure the continued availability of these tablets to meet the needs of the federal government, specifically for troop support and related healthcare requirements. Contractors are expected to provide products that meet all applicable regulatory standards for safety, efficacy, and quality, as outlined in the attached solicitation document. Key requirements for this opportunity include the manufacturing and supply of Norgestimate/Ethinyl Estradiol Tablets in accordance with federal specifications. Prospective contractors should possess the necessary capabilities in pharmaceutical preparation manufacturing, including appropriate certifications, quality assurance processes, and the ability to deliver consistent product volumes as specified in the solicitation. The expected deliverables are the timely and compliant provision of the tablets, with all associated documentation and labeling as required by federal procurement standards. The contracting entity for this solicitation is DLA Troop Support, a federal office responsible for providing logistical support to military and other government operations. Interested parties may direct inquiries to the primary contact, Kyle Lewicki ([email protected], 215-737-3696), or the secondary contact, Jason C. Wray ([email protected], 215-737-0614), for further information regarding the solicitation and submission requirements. This procurement is being conducted as a formal solicitation, and all interested contractors are encouraged to review the attached solicitation document for detailed instructions and requirements. The notice was posted on December 19, 2024, and responses are due by January 21, 2025, at 20:01. The opportunity remains active and can be accessed via the official SAM.gov portal at https://sam.gov/opp/246511ab08fa4dfd9fa279d65bc5deb2/view. No specific set-aside requirements or special considerations have been indicated in the provided information. Contractors should ensure their capabilities align with the pharmaceutical manufacturing scope and federal compliance standards outlined in the solicitation. This opportunity represents a consistent and ongoing need for pharmaceutical products within the federal supply chain, and successful contractors will be expected to maintain high standards of quality and reliability throughout the contract lifecycle.